IP Verse

Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant Regions

Patent No. EP3626819 (titled "Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant Regions") was filed by Regeneron Pharmaceuticals on Feb 15, 2002. The application was issued on Mar 31, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KYMABDec 22, 2021CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3626819

REGENERON PHARMACEUTICALS
Application Number
EP19203913A
Filing Date
Feb 15, 2002
Status
Granted And Under Opposition
Feb 26, 2021
Publication Date
Mar 31, 2021
External Links
Slate, Register , Google Patents